CLB

Core Laboratories Inc. (CLB) | Rumor.io

Core Laboratories

CLB

Attention (50-day avg)0%

Attention rank (50-day avg)#4,592

Bullish sentiment (50-day avg)0%

Price to earnings ratio19.7

Market capitalization460.2M

Earnings per share0.52

Dividend yield (TTM)0.4%

Revenue (annual)526.5M

Net income (annual)30.4M

Social

What share of all stock conversation is about CLB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Oct 23

Core Laboratories N.V. (CLB) reported strong Q3 results, beating revenue and EPS guidance, driven by margin expansion and robust international activity.
The company's Q4 outlook was muted, but the Q3 performance was driven by strong demand in energy services, with revenue of $134.5M and net income of $14.24M.
CLB's stock price surged by 28.82% following a patent approval breakthrough, suggesting sustained momentum ahead.

Generated by AI

Sentiment

Of the messages about CLB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0%	82.72% +9.25
Bearish	—	—	100%	17.28% -9.25

Bullish· Aug 11

$CLB is expected to make significant moves this week, with some posts suggesting it will "push limits" and "shock many" with its performance.
Core Laboratories N.V. has a strong foundation in place for growth, with posts highlighting its "resilience" and "market strength".
$CLB is seen as a promising investment opportunity, with some posts suggesting it will "climb" and "write the success story" for those who invest early.

Bearish· Dec 31

$CLB's dividend cut is 20% worse than expected, with the stock pricing in the delta, indicating a significant negative impact on the industry leader.
The company's guidance cut and reduced dividend are expected to be recurring themes, particularly in North America, where activity is already tough.
$CLB's 55% cut to its quarterly dividend is a clear sign that the decks are being cleared, with the stock likely to continue its drop, especially with the upcoming return of investors from vacation.

Generated by AI

Topics

Of the messages about CLB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	50%	63.89%
Controversies	—	—	50%	2.78%
Analysts	—	—	0%	0%
Earnings	—	—	0%	16.67%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	16.67%

Earnings· Jul 25

Core Laboratories N.V. ($CLB) reported FQ2 earnings of 59c EPS and $175.48M in revenue.
$CLB missed the Estimize EPS consensus by 1c and the Estimize revenue consensus by $0.14M.
$CLB's reported earnings of $0.59 were in-line with estimates, while revenues slightly beat expectations.

Announcements· Dec 31

Core Laboratories ($CLB) has signed deals that will lead to exponential revenue growth.
The company has provided Q1 2020 earnings guidance, with after-hours updates available.
Core Laboratories has also issued Q4 earnings guidance and slashed its dividend, with $CLB shares being impacted by the news.

Generated by AI

Community

Of the messages about CLB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	71.43%	12.98%
Newcomers	—	—	28.57%	87.02%

Regulars· Oct 26

$CLB reported earnings of $0.18, beating the consensus estimate of $0.09.
Core Laboratories' Q3 revenue was $126M, meeting expectations and up 4% sequentially and 7% year-over-year.
Analyst_7579453 correctly predicted $CLB's earnings beat, outperforming 8 other analysts and the Wall Street consensus.

Newcomers· Dec 31

The company's dividend cut is seen as a negative sign for the oilfield services sector, with some analysts expecting tough times ahead, particularly in North America.
The dividend cut was worse than expected, with the stock pricing in the delta, and the CEO's leadership is being questioned, with some calling for his removal.
Despite a brief ascending triangle breakout and buying volume, the stock's recent performance is seen as a negative sign, with some analysts anticipating further potential pitfalls in the 2020s.

Generated by AI

News

Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories

Oilfield services face spending and debt challenges, but TechnipFMC, Oceaneering and Core Laboratories show resilience and growth potential.

27d agoYahoo Finance

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

1mo agoYahoo Finance

Core Laboratories (CLB) Q2 2026 Earnings Call Transcript

Detailed price information for Core Laboratories Inc (CLB-N) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.

2mo agoYahoo Finance

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.

2mo agoYahoo Finance

Earnings call transcript: Core Laboratories misses Q2 2026 EPS forecast

2mo agoInvesting.com

Also Discussed

Investors talking about CLB also mention

#	Name	Attention
1	EOG Resources IncEOG	0%+0
2	Schlumberger LimitedSLB	0%0
3	NOV Inc.NOV	0%0
4	iShares International Select Dividend ETFIDV	0%0
5	The Marygold Companies, Inc.MGLD	0%+0
6	MSC Industrial Direct Co., Inc. Class AMSM	0%new
7	Halliburton CompanyHAL	0%new
8	PXD - Pioneer Natural Resources Company	——
9	WEC Energy Group Inc.WEC	0%new
10	GMS - GMS Inc.	——

Core Laboratories Inc.

Energy
Oil & Gas Equipment & Services

Core Laboratories Inc. is an oilfield services company that provides specialized reservoir description and production enhancement services and products to the oil and gas industry. Core Laboratories Inc. helps customers evaluate reservoir rock and fluid properties, improve well performance, and increase recovery from new and existing fields through laboratory analysis, field services, and proprietary technologies. Its business is organized into Reservoir Description and Production Enhancement, two complementary segments that support exploration, development, and production decisions. The company serves major, national, and independent oil companies across international markets, with operations in more than 50 countries. Core Laboratories Inc. also applies its technical expertise to subsurface evaluation work related to carbon capture and sequestration projects, reflecting its role in advanced energy and reservoir analysis.

Website

Location

6316 Windfern Road

Houston, TX, 77040

United States

Social

What share of all stock conversation is about CLB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Oct 23

Core Laboratories N.V. (CLB) reported strong Q3 results, beating revenue and EPS guidance, driven by margin expansion and robust international activity.
The company's Q4 outlook was muted, but the Q3 performance was driven by strong demand in energy services, with revenue of $134.5M and net income of $14.24M.
CLB's stock price surged by 28.82% following a patent approval breakthrough, suggesting sustained momentum ahead.

Generated by AI

Sentiment

Of the messages about CLB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0%	82.72% +9.25
Bearish	—	—	100%	17.28% -9.25

Bullish· Aug 11

$CLB is expected to make significant moves this week, with some posts suggesting it will "push limits" and "shock many" with its performance.
Core Laboratories N.V. has a strong foundation in place for growth, with posts highlighting its "resilience" and "market strength".
$CLB is seen as a promising investment opportunity, with some posts suggesting it will "climb" and "write the success story" for those who invest early.

Bearish· Dec 31

$CLB's dividend cut is 20% worse than expected, with the stock pricing in the delta, indicating a significant negative impact on the industry leader.
The company's guidance cut and reduced dividend are expected to be recurring themes, particularly in North America, where activity is already tough.
$CLB's 55% cut to its quarterly dividend is a clear sign that the decks are being cleared, with the stock likely to continue its drop, especially with the upcoming return of investors from vacation.

Generated by AI

Topics

Of the messages about CLB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	50%	63.89%
Controversies	—	—	50%	2.78%
Analysts	—	—	0%	0%
Earnings	—	—	0%	16.67%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	16.67%

Earnings· Jul 25

Core Laboratories N.V. ($CLB) reported FQ2 earnings of 59c EPS and $175.48M in revenue.
$CLB missed the Estimize EPS consensus by 1c and the Estimize revenue consensus by $0.14M.
$CLB's reported earnings of $0.59 were in-line with estimates, while revenues slightly beat expectations.

Announcements· Dec 31

Core Laboratories ($CLB) has signed deals that will lead to exponential revenue growth.
The company has provided Q1 2020 earnings guidance, with after-hours updates available.
Core Laboratories has also issued Q4 earnings guidance and slashed its dividend, with $CLB shares being impacted by the news.

Generated by AI

Community

Of the messages about CLB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	71.43%	12.98%
Newcomers	—	—	28.57%	87.02%

Regulars· Oct 26

$CLB reported earnings of $0.18, beating the consensus estimate of $0.09.
Core Laboratories' Q3 revenue was $126M, meeting expectations and up 4% sequentially and 7% year-over-year.
Analyst_7579453 correctly predicted $CLB's earnings beat, outperforming 8 other analysts and the Wall Street consensus.

Newcomers· Dec 31

The company's dividend cut is seen as a negative sign for the oilfield services sector, with some analysts expecting tough times ahead, particularly in North America.
The dividend cut was worse than expected, with the stock pricing in the delta, and the CEO's leadership is being questioned, with some calling for his removal.
Despite a brief ascending triangle breakout and buying volume, the stock's recent performance is seen as a negative sign, with some analysts anticipating further potential pitfalls in the 2020s.

Generated by AI

Core Laboratories

Social

Oct 23

Bullish· Aug 11

Bearish· Dec 31

Earnings· Jul 25

Announcements· Dec 31

Regulars· Oct 26

Newcomers· Dec 31

Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) Q2 2026 Earnings Call Transcript

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

Earnings call transcript: Core Laboratories misses Q2 2026 EPS forecast

Also Discussed

Core Laboratories Inc.

Company Information

Location

Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) Q2 2026 Earnings Call Transcript

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

Earnings call transcript: Core Laboratories misses Q2 2026 EPS forecast

Also Discussed

Social

Oct 23

Bullish· Aug 11

Bearish· Dec 31

Earnings· Jul 25

Announcements· Dec 31

Regulars· Oct 26

Newcomers· Dec 31